LYON, FRANCE—The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) opened its 2012 annual meeting in Lyon, France, on October 10, 2012. According to meeting organizers, attendance at the 28th Congress of ECTRIMS nearly matched that of last year, which was a joint meeting of ECTRIMS and the American Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS). The total number of participants is estimated at 7,121, with attendees representing 96 countries. The United States, Germany, and France lead the list of countries represented.
Nearly 1,400 abstracts were submitted for presentation this year. Of these, 77 oral presentations were accepted, 931 poster presentations were accepted, and 373 abstracts were rejected.
Major topics covered at this year’s meeting include: the environmental influence on MS pathogenesis, genetics and MS, inflammation and degeneration, adaptation immunity and innate immunity, disability, pregnancy and MS, biology of recovery, disease monitoring, databases and cohorts, progressive multifocal leukoencephalopathy (PML) and immune reconstitution inflammatory syndrome (IRIS), cognition, natural to treated disease history, and neuromyelitis optica.
—Glenn S. Williams